Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

St Mary's Hospital · Imperial College London

PubMed
Indexed incrossrefpubmed

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents a histological spectrum of liver disease associated with obesity, diabetes and insulin resistance that extends from isolated steatosis to steatohepatitis and cirrhosis. As well as being a potential cause of progressive liver disease in its own right, steatosis has been shown to be an important cofactor in the pathogenesis of many other liver diseases. Animal models of NAFLD may be divided into two broad categories: those caused by genetic mutation and those with an acquired phenotype produced by dietary or pharmacological manipulation. The literature contains numerous different mouse models that exhibit histological evidence of hepatic steatosis or, more…

Citation impact

708
total citations
FWCI
13.13
Percentile
100%
References
132
Citations per year

Authors

2

Topics & keywords

Keywords
  • Steatohepatitis
  • Fatty liver
  • Steatosis
  • Cirrhosis
  • Disease
  • Pathogenesis
  • Liver disease
  • Biology
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.